GeoVax Labs Ownership
| GOVX Stock | USD 2.95 0.25 9.26% |
Shares in Circulation | First Issued 2000-03-31 | Previous Quarter 2.5 M | Current Value 6.4 M | Avarage Shares Outstanding 719.4 K | Quarterly Volatility 1.7 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
GeoVax |
GeoVax Stock Ownership Analysis
The book value of the company was currently reported as 2.92. The company recorded a loss per share of 8.39. GeoVax Labs last dividend was issued on the 25th of September 2020. The entity had 1:15 split on the 31st of January 2024. GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. GeoVax Labs, Inc. was incorporated in 1988 and is based in Smyrna, Georgia. Geovax Labs operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 11 people. To learn more about GeoVax Labs call the company at 678 384 7220 or check out https://www.geovax.com.Besides selling stocks to institutional investors, GeoVax Labs also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different GeoVax Labs' stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align GeoVax Labs' strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
GeoVax Labs Quarterly Liabilities And Stockholders Equity |
|
GeoVax Labs Insider Trades History
Less than 1% of GeoVax Labs are currently held by insiders. Unlike GeoVax Labs' institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against GeoVax Labs' private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of GeoVax Labs' insider trades
GeoVax Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as GeoVax Labs is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading GeoVax Labs backward and forwards among themselves. GeoVax Labs' institutional investor refers to the entity that pools money to purchase GeoVax Labs' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Global Retirement Partners, Llc. | 2024-09-30 | 27.0 | Duncker Streett & Co Inc | 2024-09-30 | 24.0 | Royal Bank Of Canada | 2024-06-30 | 4.0 | Fmr Inc | 2024-09-30 | 1.0 | Jpmorgan Chase & Co | 2024-06-30 | 0.0 | Renaissance Technologies Corp | 2024-09-30 | 266 K | Armistice Capital, Llc | 2024-06-30 | 80 K | Bank Of America Corp | 2024-06-30 | 44.8 K | Blackrock Inc | 2024-06-30 | 27.6 K | Vanguard Group Inc | 2024-09-30 | 19.2 K | Geode Capital Management, Llc | 2024-06-30 | 13.9 K |
GeoVax Labs Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific GeoVax Labs insiders, such as employees or executives, is commonly permitted as long as it does not rely on GeoVax Labs' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases GeoVax Labs insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Reynolds Mark over a month ago Acquisition by Reynolds Mark of 128000 shares of GeoVax Labs at 2.79 subject to Rule 16b-3 | ||
Spencer John N Jr over three months ago Acquisition by Spencer John N Jr of 8050 shares of GeoVax Labs at 2.17 subject to Rule 16b-3 | ||
David Dodd over three months ago Acquisition by David Dodd of 8000 shares of GeoVax Labs at 1.95 subject to Rule 16b-3 | ||
Chase Randal D over three months ago Acquisition by Chase Randal D of 9800 shares of GeoVax Labs at 0.19 subject to Rule 16b-3 | ||
John Sharkey over three months ago Acquisition by John Sharkey of 1000 shares of GeoVax Labs at 0.82 subject to Rule 16b-3 | ||
Mark Reynolds over six months ago Purchase by Mark Reynolds of 2000 shares of GeoVax Labs | ||
Mark Reynolds over a year ago Purchase by Mark Reynolds of 10000 shares of GeoVax Labs | ||
Mark Reynolds over a year ago Acquisition by Mark Reynolds of 100000 shares of GeoVax Labs subject to Rule 16b-3 | ||
Mark Reynolds over a year ago Purchase by Mark Reynolds of 8000 shares of GeoVax Labs |
GeoVax Labs Outstanding Bonds
GeoVax Labs issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. GeoVax Labs uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most GeoVax bonds can be classified according to their maturity, which is the date when GeoVax Labs has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
GeoVax Labs Corporate Filings
8K | 18th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 14th of November 2024 An amended filing to the original Schedule 13G | ViewVerify |
10Q | 12th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
| 15th of October 2024 Other Reports | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for GeoVax Stock Analysis
When running GeoVax Labs' price analysis, check to measure GeoVax Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeoVax Labs is operating at the current time. Most of GeoVax Labs' value examination focuses on studying past and present price action to predict the probability of GeoVax Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeoVax Labs' price. Additionally, you may evaluate how the addition of GeoVax Labs to your portfolios can decrease your overall portfolio volatility.